Better-than-expected top and bottom lines weren't enough to make investors happy for one key reason.
News & Analysis: Lannett
LCI earnings call for the period ending June 30, 2020.
Investors responded enthusiastically to the company's new generic distribution deal.
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
The company released its earnings report for the third quarter of its fiscal year 2020.
LCI earnings call for the period ending March 31, 2020.
The generic-drug maker's revenue and earnings fell in Q2. But there were still several positives in Lannett's quarterly update.
LCI earnings call for the period ending December 31, 2019.
A small-cap drug maker just got approval for an anesthetic containing cocaine.
LCI earnings call for the period ending September 30, 2019.